Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Moving Toward Individualized Treatment Recommendations for Chemotherapy after Lung Cancer Surgery
Author
Howard (Jack) West, MD

A recent trial by Olaussen and colleagues was just published in the New England Journal of Medicine that suggested that in the future oncologists may become better at identifying the patients who are more or less likely to benefit from chemotherapy after surgery for early stage non-small cell lung cancer. At this point, the marker that was being evaluated is not readily available and hasn’t been validated, but it’s a very promising lead. In this trial, the group with tumors that have low expression of this protein, called ERCC-1 (which repairs DNA damage induced from cisplatin-based chemo), did better with chemo than if they didn’t get it. The other group, who had high expression of ERCC-1 on their tumors, did better if they didn’t get chemo than if they did. Because chemo can have some unpleasant and sometimes dangerous side effects, clarifying who is more likely to benefit and who will get just side effects and no benefits would be a great help.

This adds to the conclusions from work of others, such as Dr. Rafael Rosell in Barcelona, Spain and by Dr. Gerold Bepler at Moffett Cancer Center in Tampa, FL, who have both done studies suggesting that tumor markers can soon help us predict who will benefit from certain types of chemotherapy and who will be less likely to benefit.

The limits of this study are that it was retrospective, or reviewing what was available after the fact, and that it included only tissue from a subgroup, about 40% of tumors from patients on the study. This work needs to be corroborated by further trials, especially ones that look at these questions prospectively (planned going into the study, so everyone’s tissue is included). These marker studies are not routinely performed or widely available. Before using such markers for clinical decision-making, we need to standardize how the marker studies are done and interpreted. However, this work is an early indication of how we hope to further treatment recommendations for patients with cancer in the near future.

Next Previous link

Previous PostNext Post

Related Content

Image
Clinical Trials Storytelling 2025
Article
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
Article
Imagine your body's defense system, the lymphatic system, suddenly turning against you. This is the reality for those facing lymphoma, a cancer of the immune system's crucial network. This article delves into the complexities of lymphoma, exploring its various forms, from the aggressive to the indolent, and examining the latest breakthroughs in treatment, including the groundbreaking POLARIX trial and cutting-edge therapies for relapsed cases. Whether you're a patient, a loved one, or simply curious about this complex disease, this comprehensive overview will provide valuable insights into the current state of lymphoma care and the promising future of research.
Image
Melanoma Video Library
Video
In these videos, Dr. Autumn Starnes gives an overview of melanoma's prevalence and risk factors. She also discusses the ABCDE method of self-screening for skin cancer, common misconceptions regarding people of color, and melanoma, and how a person can lower their risk of developing melanoma, among other relevant topics regarding melanoma.  To watch the complete playlist, click here. 

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Glad to help.  FYI, I just edited the link, which has the agenda and links to oncologists' bios. Plus, the link is also on our home page, https://cancergrace.org/

Hope to see...

Recent Comments

JOIN THE CONVERSATION
Glad to help.  FYI, I just…
By JanineT GRACE … on
I was searching for this,…
By LilahStapleton on
Hi and welcome.  I'm sorry…
By JanineT GRACE … on
Hi amitchouhan,

Welcome to…
By JanineT GRACE … on